The Solid Tumors Center at Dana-Farber/Boston Children's Cancer and Blood Disorders Center treats children and teens with a variety of solid malignancies, including bone and soft-tissue tumors, liver and kidney tumors, neuroblastoma, retinoblastoma, and rare tumors. Our doctors provide unparalleled expertise in the diagnosis, treatment and management of these diseases.
Dana-Farber/Boston Children's Solid Tumors Center offers patients the most advanced diagnostics and treatments available, including:
Bone and soft tissue tumors form in the body's connective tissues, which include bone, cartilage, blood and fat. These tumors fall into two major categories: benign (non-cancerous) and malignant (cancerous).
Specialists in the Bone and Soft Tissue Program at Dana-Farber/Boston Children's Cancer and Blood Disorders Center have expertise in treating a wide range of newly diagnosed and relapsed musculoskeletal cancers and benign tumors, including:
Learn more about our Bone and Soft Tissue Program.
Dana-Farber/Boston Children's Cancer and Blood Disorders Center treats all primary liver cancers occurring in children and teens. The two most common types of liver cancer are hepatoblastoma and hepatocellular carcinoma. We care for both newly diagnosed liver cancer and for children with relapsed disease.
Learn more about our Liver Cancer Treatment Program.
Neuroblastoma is a cancerous tumor that begins in nerve tissues of very young children. The Neuroblastoma Program treats newly diagnosed and relapsed patients and provides innovative therapies for children with hard-to-treat neuroblastomas.
Learn more about our Neuroblastoma Treatment Program.
At Dana-Farber/Boston Children's Cancer and Blood Disorders Center, we are committed to providing exceptional care for children with rare cancerous conditions. Our Rare Tumors Program offers the latest therapies and clinical trials, and provides access to pediatric experts with extensive experience treating children and teens with rare solid tumors.
The disease conditions we treat include:
Learn more about our Rare Tumors Treatment Program.
Retinoblastoma is a malignant tumor in the retina, the light-detecting cells at the back of the eye. The Retinoblastoma Program offers the latest in diagnosis and treatment options, as well as access to a wide range of pediatric subspecialists to help you and your child manage any treatment challenges and transition back to school and other activities.
Learn more about our Retinoblastoma Treatment Program.
Specialists at the Solid Tumors Center also treat the following disease conditions:
Browse clinical trials
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: